Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM-020 Gel 1.0% in Dermatosis Papulosa Nigra
NCT06099080Phase 2Active, not recruiting
- Sponsor
- DermBiont, Inc.
- Start
- Nov 2023
- Primary completion
- Jul 2024
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SM-020 in dermatosis papulosa nigra (DPN), sponsored by DermBiont, Inc.. Started Nov 2023; status: active, not recruiting.
02
Drugs
SM-020
03
Conditions
dermatosis papulosa nigra (DPN)
Beyond the preview
Go deeper on NCT06099080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06099080.